Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

APGE stock hub

Apogee Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

APGEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.2B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

APGE

In the news

Latest news · APGE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-31.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-21.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All APGE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

USD

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001974640
Company name	Apogee Therapeutics, Inc.
Country	United States
Country code	US
Cusip	432705309
Employees	261
Employees Change	65%
Employees Change Percent	33.16
Enterprise value	$5.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2023-07-14
Isin	US03770N1019
Last refreshed	2026-05-10
Market cap	$6.2B
Market cap category	Mid-Cap
Price	$83.03
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	APGE
Website	https://www.apogeetherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.12%
FCF yield	-3.75%
P/B ratio	6.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-255.8M
Net Income Growth Years	0%
Profit Per Employee	$-980,241
ROA	-21.11
ROCE	-31.41
ROE	-31.57
ROIC	-21.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	135.75%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$937.1M
Cash	$730.2M
Current Assets	$741.4M
Current Liabilities	$27.9M
Debt	$8.8M
Debt Equity	$0.01
Equity	$903.9M
Liabilities	$33.3M
Long Term Assets	$195.8M
Long Term Liabilities	$5.3M
Net Cash	$894.1M
Net Cash By Market Cap	$14.41
Net Cash Growth	24.31%
Net Debt Equity	$-0.99
Tangible Book Value	$903.9M
Tangible Book Value Per Share	$13.21
WACC	8.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	26.57
Net Working Capital	$-13.2M
Quick ratio	26.38
Working Capital	$713.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.96%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	135.61%
200-day SMA	62.93
50-day SMA	80.15
50-day SMA vs 200-day SMA	50over200
All Time High	95.32
All Time High Change	-12.89%
All Time High Date	2026-04-17
All Time Low	14.19
All Time Low Change	485.13%
All Time Low Date	2023-11-10
ATR	3.61
Beta	0.69
Beta1y	0.3
Beta2y	1.06
Ch YTD	10
High	84.15
High52	95.32
High52 Date	2026-04-17
High52ch	-12.89%
Low	82.06
Low52	34.34
Low52 Date	2025-08-08
Low52ch	141.79%
Ma50ch	3.6%
Premarket Change Percent	0.46
Premarket Price	$82.19
Premarket Volume	350
Price vs 200-day SMA	31.94%
RSI	48.62
RSI Monthly	69.1
RSI Weekly	60.11
Sharpe ratio	1.69x
Sortino ratio	2.97
Total Return	-9.96%
Tr YTD	10
Tr1m	-0.3%
Tr1w	2.82%
Tr3m	33.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	14
Analyst Count Top	7
Analyst Price Target Top	$117
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.13
Operating Income	$-285.6M
Price target	$112
Price Target Change	$34.89
Price Target Change Top	$41.12

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	57,598,680%
Float Percent	77.1%
Shares Insiders	2.1%
Shares Institutions	90.79%
Shares Out	74,702,302
Shares Qo Q	14.61%
Shares Yo Y	9.96%
Short Float	16.61%
Short Ratio	8.07
Short Shares	12.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-278.9M
Average Volume	598,873.85x
Bv Per Share	13.21
CAPEX	$-5.1M
Ch1m	-0.3
Ch1w	2.82
Ch1y	135.6
Ch3m	33.4
Ch6m	51.76
Change	1.49%
Change From Open	0.33
Close	81.81
Days Gap	1.16
Depreciation Amortization	1,418,000
Dollar Volume	57,243,455.9
Earnings Date	2026-05-12
Earnings Time	bmo
EBIT	$-285.6M
EBITDA	$-284.2M
EPS	$-4.22
F Score	2
FCF	$-232.6M
FCF EV Yield	-4.38x
FCF Per Share	$-3.11
Financing CF	396,490,000
Fiscal Year End	December
Founded	2,022
Income Tax	$278,000
Investing CF	-179,574,000
Ipr	388.4
Iprfo	286.2
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-02
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-02
Ma150	71.34
Ma150ch	16.38%
Ma20	86.37
Ma20ch	-3.87%
Net CF	-10,534,000
Next Earnings Date	2026-05-22
Open	82.76
Optionable	Yes
Position In Range	46.41
Ppne	14,375,000
Pre Close	81.81
Price Date	2026-05-08
Ptbv Ratio	6.86
Relative Volume	1.15x
Share Based Comp	46,277,000
Tr6m	51.76%
Us State	Massachusetts
Volume	689,431

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does APGE pay a dividend?

Capital-return profile for this ticker.

Performance

APGE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns APGE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+90.8%

Float: +77.1% of shares outstanding

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

APGE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.6

Neutral momentum band

Price vs 200-day MA

+31.9%

50/200-day relationship not available

Beta (5Y)

0.69

Less volatile than the market

Sharpe ratio

1.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About APGE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current APGE stock rating?

Apogee Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full APGE analysis?

The full report lives at /stocks/APGE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for APGE?

The latest report frames APGE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the APGE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.